Back to search

A Study of JNJ-88998377 for Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma

Lymphoma, Non-Hodgkin
Refractory B-Cell NHL
Relapsed B-cell NHL
Clinicaltrials.gov:
EU CTIS:
#2023-509258-71-00
Other:
#88998377LYM1001
Subscribe or share this trial
Countries:
  • China,
  • Italy,
  • Japan,
  • Poland,
  • South Korea,
  • Taiwan,
  • Turkey (Türkiye)
Loading...
Bologna, Italy, 40138
Skorzewo, Poland, 60-185
Ankara, Turkey (Türkiye), 06620
Beijing, China, 100142
Shanghai, China, 200032
Istanbul, Turkey (Türkiye), 34010
Taoyuan District, Taiwan, 33382
Chūōku, Japan, 104 0045
Kashiwa, Japan, 277-8577
Taipei, Taiwan, 10043
Katowice, Poland, 40 519
Ankara, Turkey (Türkiye), 06200
Seoul, South Korea, 06351
Seoul, South Korea, 03080
Guangzhou, China, 510062
Kielce, Poland, 25-734
Tokyo, Japan, 135 8550
Hangzhou, China, 310002
Tianjin, China, 300181
#
More than 50 sites in this region
#
More than 10 sites in this region
#
Less than 10 sites in this region
Map pin icon representing individual study sites
Individual sites
Access detailed information on the trial:
© Johnson & Johnson and its affiliates 2026
J&J Clinical Trials